rs35370270
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_025074.7(FRAS1):āc.11227A>Gā(p.Ile3743Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000604 in 1,614,026 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_025074.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRAS1 | NM_025074.7 | c.11227A>G | p.Ile3743Val | missense_variant | 72/74 | ENST00000512123.4 | NP_079350.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.11227A>G | p.Ile3743Val | missense_variant | 72/74 | 5 | NM_025074.7 | ENSP00000422834.2 |
Frequencies
GnomAD3 genomes AF: 0.00325 AC: 494AN: 152224Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.000799 AC: 199AN: 249158Hom.: 0 AF XY: 0.000599 AC XY: 81AN XY: 135168
GnomAD4 exome AF: 0.000325 AC: 475AN: 1461684Hom.: 2 Cov.: 31 AF XY: 0.000305 AC XY: 222AN XY: 727120
GnomAD4 genome AF: 0.00328 AC: 500AN: 152342Hom.: 5 Cov.: 32 AF XY: 0.00309 AC XY: 230AN XY: 74494
ClinVar
Submissions by phenotype
not provided Benign:6
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | FRAS1: BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 04, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.11227A>G (p.I3743V) alteration is located in exon 72 (coding exon 72) of the FRAS1 gene. This alteration results from a A to G substitution at nucleotide position 11227, causing the isoleucine (I) at amino acid position 3743 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at